After finishing at $1.86 in the prior trading day, ATAI Life Sciences N.V. (NASDAQ: ATAI) closed at $1.87, up 0.54%. In other words, the price has increased by $+0.0100 from its previous closing price. On the day, 926244 shares were traded.
Ratios:
Our goal is to gain a better understanding of ATAI by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.22 and its Current Ratio is at 9.22. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.07.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Loop Capital on November 01, 2022, initiated with a Buy rating and assigned the stock a target price of $18.
On November 30, 2021, Maxim Group started tracking the stock assigning a Buy rating and target price of $25.
On November 11, 2021, ROTH Capital started tracking the stock assigning a Buy rating and target price of $32.ROTH Capital initiated its Buy rating on November 11, 2021, with a $32 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 16 ’23 when Brand Florian bought 20,000 shares for $1.16 per share. The transaction valued at 23,120 led to the insider holds 130,000 shares of the business.
Brand Florian bought 40,000 shares of ATAI for $57,968 on Sep 13 ’23. The insider now owns 110,000 shares after completing the transaction at $1.45 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ATAI now has a Market Capitalization of 310.47M and an Enterprise Value of 150.35M. For the stock, the TTM Price-to-Sale (P/S) ratio is 1001.54 while its Price-to-Book (P/B) ratio in mrq is 1.28. Its current Enterprise Value per Revenue stands at 478.84 whereas that against EBITDA is -4.14.
Stock Price History:
Over the past 52 weeks, ATAI has reached a high of $2.39, while it has fallen to a 52-week low of $1.02. The 50-Day Moving Average of the stock is 1.8412, while the 200-Day Moving Average is calculated to be 1.6016.
Shares Statistics:
The stock has traded on average 1.56M shares per day over the past 3-months and 1.38M shares per day over the last 10 days, according to various share statistics. A total of 166.03M shares are outstanding, with a floating share count of 115.36M. Insiders hold about 30.51% of the company’s shares, while institutions hold 8.22% stake in the company. Shares short for ATAI as of Mar 15, 2024 were 5.21M with a Short Ratio of 3.35, compared to 4.87M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 3.14% and a Short% of Float of 4.10%.
Earnings Estimates
Its stock is currently analyzed by 3 different market analysts. On average, analysts expect EPS of -$0.16 for the current quarter, with a high estimate of -$0.14 and a low estimate of -$0.18, while EPS last year was -$0.21. The consensus estimate for the next quarter is -$0.17, with high estimates of -$0.16 and low estimates of -$0.19.
Analysts are recommending an EPS of between -$0.65 and -$0.8 for the fiscal current year, implying an average EPS of -$0.7. EPS for the following year is -$0.69, with 5 analysts recommending between -$0.52 and -$0.89.
